UnitedHealth Grew to Be a Leviathan. Then Came the Backlash.

UnitedHealth, one of the largest healthcare conglomerates in the United States, has faced a backlash from patients and investors due to its rapid growth and perceived business practices. The company, once praised for its success, is now viewed with skepticism by many. Patients have expressed outrage over the company's policies and decisions, which they believe prioritize profits over patient care. Investors, too, have lost faith in UnitedHealth's business model, as the company's stock price has faltered in recent years. The article suggests that UnitedHealth's rapid expansion and diversification into various healthcare sectors, including insurance, pharmacy, and data analytics, have contributed to the growing public and investor discontent. Critics argue that the company's size and market dominance have enabled it to exert undue influence over the healthcare industry, leading to higher costs and reduced access to care for many Americans. The backlash against UnitedHealth highlights the broader tensions and challenges facing the U.S. healthcare system, as policymakers and the public grapple with the role of large, profit-driven conglomerates in the provision of essential medical services.